BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 24794246)

  • 21. Comparison of three enzyme-linked immunosorbent assays to detect Porcine circovirus-2 (PCV-2)-specific antibodies after vaccination or inoculation of pigs with distinct PCV-1 or PCV-2 isolates.
    Patterson AR; Johnson J; Ramamoorthy S; Meng XJ; Halbur PG; Opriessnig T
    J Vet Diagn Invest; 2008 Nov; 20(6):744-51. PubMed ID: 18987223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular and humoral immunity following vaccination with two different PCV2 vaccines (containing PCV2a or PCV2a/PCV2b) and challenge with virulent PCV2d.
    Venegas-Vargas C; Taylor LP; Foss DL; Godbee TK; Philip R; Bandrick M
    Vaccine; 2021 Sep; 39(39):5615-5625. PubMed ID: 34420789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pilot comparative study of recombinant protein and whole-virus inactivated vaccines against porcine circovirus type 2 in conventionally reared pigs.
    Choi JY; Lyoo KS; Kim K; Do VT; Lee KW; Hahn TW
    Res Vet Sci; 2019 Apr; 123():192-194. PubMed ID: 30682582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of four commercial one-dose porcine circovirus type 2 (PCV2) vaccines administered to pigs challenged with PCV2 and porcine reproductive and respiratory syndrome virus at 17 weeks postvaccination to control porcine respiratory disease complex under Korean field conditions.
    Park C; Seo HW; Han K; Chae C
    Clin Vaccine Immunol; 2014 Mar; 21(3):399-406. PubMed ID: 24403524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective immunity in swine induced by Porcine Circovirus 2b inactivated vaccines with different antigen payload.
    Guarneri F; Tresoldi ET; Sarli G; Boniotti MB; Lelli D; Barbieri I; Bacci B; D'Annunzio G; Amadori M
    Vet Microbiol; 2021 Jan; 252():108887. PubMed ID: 33276254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A PCV2 vaccine based on genotype 2b is more effective than a 2a-based vaccine to protect against PCV2b or combined PCV2a/2b viremia in pigs with concurrent PCV2, PRRSV and PPV infection.
    Opriessnig T; O'Neill K; Gerber PF; de Castro AM; Gimenéz-Lirola LG; Beach NM; Zhou L; Meng XJ; Wang C; Halbur PG
    Vaccine; 2013 Jan; 31(3):487-94. PubMed ID: 23174198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlates of Protection Following Vaccination with Inactivated Porcine Circovirus 2 Vaccines.
    Zanotti C; Martinelli N; Lelli D; Amadori M
    Viral Immunol; 2015 Dec; 28(10):600-8. PubMed ID: 26401584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PCV2 vaccination induces IFN-γ/TNF-α co-producing T cells with a potential role in protection.
    Koinig HC; Talker SC; Stadler M; Ladinig A; Graage R; Ritzmann M; Hennig-Pauka I; Gerner W; Saalmüller A
    Vet Res; 2015 Mar; 46():20. PubMed ID: 25888899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of the timing of the administration of Mycoplasma hyopneumoniae bacterin on the development of lesions associated with porcine circovirus type 2.
    Opriessnig T; Halbur PG; Yu S; Thacker EL; Fenaux M; Meng XJ
    Vet Rec; 2006 Feb; 158(5):149-54. PubMed ID: 16461621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Porcine circovirus type 2b (PCV2b)-based experimental vaccine is effective in the PCV2b-Mycoplasma hyopneumoniae coinfection pig model.
    Opriessnig T; Castro AMMG; Karuppanan AK; Gauger PC; Halbur PG; Matzinger SR; Meng XJ
    Vaccine; 2019 Oct; 37(44):6688-6695. PubMed ID: 31537445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Field trial on the simultaneous vaccination against porcine circovirus type 2 (PCV2) and Mycoplasma hyopneumoniae].
    Herbich E; Heissenberger B; Ladinig A; Griessler A; Ritzmann M; Weissenbacher-Lang C; Hennig-Pauka I
    Tierarztl Prax Ausg G Grosstiere Nutztiere; 2013; 41(5):279-88. PubMed ID: 24126996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of high and low levels of maternally derived antibodies on porcine circovirus type 2 (PCV2) infection dynamics and production parameters in PCV2 vaccinated pigs under field conditions.
    Feng H; Segalés J; Fraile L; López-Soria S; Sibila M
    Vaccine; 2016 Jun; 34(27):3044-3050. PubMed ID: 27155497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of the immunogenicity of a porcine circovirus type 2 DNA vaccine by a recombinant plasmid coexpressing capsid protein and porcine interleukin-6 in mice.
    Guo XQ; Wang LQ; Qiao H; Yang XW; Yang MF; Chen HY
    Microbiol Immunol; 2015 Mar; 59(3):174-80. PubMed ID: 25664504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of neutralizing and non-neutralizing antibody responses against Porcine circovirus 2 in vaccinated and non-vaccinated farmed pigs.
    Solis Worsfold C; Dardari R; Law S; Eschbaumer M; Nourozieh N; Marshall F; Czub M
    J Gen Virol; 2015 Sep; 96(9):2743-2748. PubMed ID: 26033118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. One dose of a porcine circovirus 2 (PCV2) sub-unit vaccine administered to 3-week-old conventional piglets elicits cell-mediated immunity and significantly reduces PCV2 viremia in an experimental model.
    Fort M; Sibila M; Pérez-Martín E; Nofrarías M; Mateu E; Segalés J
    Vaccine; 2009 Jun; 27(30):4031-7. PubMed ID: 19379787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective humoral immunity in guinea pigs induced by PCV2 virus-like particles displaying the B cell linear epitope (
    Wang N; Zhang S; Wang D; Li F; Liang L; Li X; Zou Y; Zhan Y; Chen G; Yu W; Deng Z; Tu D; Cui S
    Vet Microbiol; 2019 Aug; 235():86-92. PubMed ID: 31282383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of maternal antibodies on efficacy of porcine circovirus type 2 (PCV2) vaccination to protect pigs from experimental infection with PCV2.
    Opriessnig T; Patterson AR; Elsener J; Meng XJ; Halbur PG
    Clin Vaccine Immunol; 2008 Mar; 15(3):397-401. PubMed ID: 18094109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inactivated PCV2 one shot vaccine applied in 3-week-old piglets: improvement of production parameters and interaction with maternally derived immunity.
    Fraile L; Grau-Roma L; Sarasola P; Sinovas N; Nofrarías M; López-Jimenez R; López-Soria S; Sibila M; Segalés J
    Vaccine; 2012 Mar; 30(11):1986-92. PubMed ID: 22245604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative efficacy of three commercial PCV2 vaccines in conventionally reared pigs.
    Lyoo K; Joo H; Caldwell B; Kim H; Davies PR; Torrison J
    Vet J; 2011 Jul; 189(1):58-62. PubMed ID: 20691624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new single-dose bivalent vaccine of porcine circovirus type 2 and Mycoplasma hyopneumoniae elicits protective immunity and improves growth performance under field conditions.
    Jeong J; Park C; Choi K; Chae C
    Vet Microbiol; 2016 Jan; 182():178-86. PubMed ID: 26711046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.